Menu
GeneBe

KIF1A

kinesin family member 1A, the group of Pleckstrin homology domain containing|Kinesins

Basic information

Region (hg38): 2:240713760-240824293

Previous symbols: [ "ATSV", "C2orf20", "SPG30" ]

Links

ENSG00000130294NCBI:547OMIM:601255HGNC:888Uniprot:Q12756AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • intellectual disability, autosomal dominant 9 (Definitive), mode of inheritance: AD
  • neuropathy, hereditary sensory, type 2C (Definitive), mode of inheritance: AR
  • intellectual disability, autosomal dominant 9 (Moderate), mode of inheritance: AD
  • neuropathy, hereditary sensory, type 2C (Limited), mode of inheritance: AR
  • hereditary spastic paraplegia 30 (Strong), mode of inheritance: AD
  • hereditary spastic paraplegia 30 (Strong), mode of inheritance: AR
  • hereditary sensory and autonomic neuropathy type 2 (Supportive), mode of inheritance: AR
  • PEHO syndrome (Supportive), mode of inheritance: AD
  • hereditary spastic paraplegia 30 (Supportive), mode of inheritance: AD
  • autosomal dominant non-syndromic intellectual disability (Supportive), mode of inheritance: AD
  • intellectual disability, autosomal dominant 9 (Strong), mode of inheritance: AD
  • neuropathy, hereditary sensory, type 2C (Strong), mode of inheritance: AR
  • hereditary spastic paraplegia 30 (Strong), mode of inheritance: AR
  • hereditary spastic paraplegia 30 (Strong), mode of inheritance: AD
  • syndromic intellectual disability (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
NESCAV syndrome; Neuropathy, hereditary sensory, type IIC; Spastic paraplegia 30, autosomal dominant; Spastic paraplegia 30, autosomal recessiveAD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic21376300; 21487076; 21820098; 22258533
Insensitivity to pain can result in injuries and infections

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the KIF1A gene.

  • Hereditary spastic paraplegia 30;Neuropathy, hereditary sensory, type 2C;Intellectual disability, autosomal dominant 9 (835 variants)
  • not provided (744 variants)
  • Neuropathy, hereditary sensory, type 2C;Intellectual disability, autosomal dominant 9;Hereditary spastic paraplegia 30 (733 variants)
  • Inborn genetic diseases (363 variants)
  • Hereditary spastic paraplegia 30 (276 variants)
  • not specified (170 variants)
  • Neuropathy, hereditary sensory, type 2C;Hereditary spastic paraplegia 30;Intellectual disability, autosomal dominant 9 (124 variants)
  • Hereditary spastic paraplegia (95 variants)
  • Intellectual disability, autosomal dominant 9 (86 variants)
  • Intellectual disability, autosomal dominant 9;Hereditary spastic paraplegia 30;Neuropathy, hereditary sensory, type 2C (69 variants)
  • Hereditary spastic paraplegia 30;Intellectual disability, autosomal dominant 9;Neuropathy, hereditary sensory, type 2C (48 variants)
  • Intellectual disability, autosomal dominant 9;Neuropathy, hereditary sensory, type 2C;Hereditary spastic paraplegia 30 (27 variants)
  • KIF1A-related condition (19 variants)
  • History of neurodevelopmental disorder (12 variants)
  • Neuropathy, hereditary sensory and autonomic, type 2A (10 variants)
  • Neuropathy, hereditary sensory, type 2C (10 variants)
  • Spastic paraplegia (8 variants)
  • Intellectual disability (7 variants)
  • Neuropathy, hereditary sensory and autonomic, type 2A;Neuropathy, hereditary sensory, type 2C;Intellectual disability, autosomal dominant 9;Hereditary spastic paraplegia 30 (7 variants)
  • Hereditary sensory and autonomic neuropathy type 2 (5 variants)
  • Spastic Paraplegia, Recessive (5 variants)
  • Intellectual Disability, Dominant (5 variants)
  • Hereditary spastic paraplegia 30;Neuropathy, hereditary sensory, type 2C;Intellectual disability, autosomal dominant 9;Neuropathy, hereditary sensory and autonomic, type 2A (4 variants)
  • Neuropathy, hereditary sensory, type 2C;Intellectual disability, autosomal dominant 9;Hereditary spastic paraplegia 30;Neuropathy, hereditary sensory and autonomic, type 2A (4 variants)
  • Hereditary spastic paraplegia 30;Neuropathy, hereditary sensory and autonomic, type 2A;Neuropathy, hereditary sensory, type 2C;Intellectual disability, autosomal dominant 9 (3 variants)
  • See cases (3 variants)
  • Neuropathy, hereditary sensory and autonomic, type 2A;Hereditary spastic paraplegia 30;Intellectual disability, autosomal dominant 9;Neuropathy, hereditary sensory, type 2C (3 variants)
  • PEHO syndrome (3 variants)
  • Developmental disorder (1 variants)
  • 19 conditions (1 variants)
  • Neurodevelopmental delay (1 variants)
  • KIF1A-related disorders (1 variants)
  • Spastic ataxia (1 variants)
  • Clonus;Hyperreflexia;Lower limb hyperreflexia;Spastic paraplegia (1 variants)
  • Neuropathy, hereditary sensory and autonomic, type 2A;Hereditary spastic paraplegia 30;Neuropathy, hereditary sensory, type 2C;Intellectual disability, autosomal dominant 9 (1 variants)
  • Intellectual disability, autosomal dominant 9;Hereditary spastic paraplegia 30 (1 variants)
  • Seizure (1 variants)
  • Neuropathy, hereditary sensory, type 2C;Hereditary spastic paraplegia 30 (1 variants)
  • KIF1A-related disorder (1 variants)
  • Intellectual disability, autosomal dominant 9;Neuropathy, hereditary sensory, type 2C;Hereditary spastic paraplegia 30;Neuropathy, hereditary sensory and autonomic, type 2A (1 variants)
  • Syndromic intellectual disability (1 variants)
  • Neuropathy, hereditary sensory, type 2C;Intellectual disability, autosomal dominant 9;Neuropathy, hereditary sensory and autonomic, type 2A;Hereditary spastic paraplegia 30 (1 variants)
  • Charcot-Marie-Tooth disease type 2 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the KIF1A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
22
clinvar
456
clinvar
10
clinvar
488
missense
30
clinvar
72
clinvar
666
clinvar
63
clinvar
6
clinvar
837
nonsense
7
clinvar
5
clinvar
2
clinvar
14
start loss
1
clinvar
1
frameshift
12
clinvar
2
clinvar
14
inframe indel
2
clinvar
1
clinvar
15
clinvar
3
clinvar
1
clinvar
22
splice donor/acceptor (+/-2bp)
6
clinvar
12
clinvar
1
clinvar
19
splice region
85
91
3
179
non coding
2
clinvar
85
clinvar
397
clinvar
144
clinvar
628
Total 57 92 794 919 161

Highest pathogenic variant AF is 0.0000197

Variants in KIF1A

This is a list of pathogenic ClinVar variants found in the KIF1A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-240713768-G-A Hereditary spastic paraplegia 30 Likely benign (Jan 13, 2018)335208
2-240713850-C-T Hereditary spastic paraplegia 30 Uncertain significance (Mar 16, 2018)898883
2-240713865-G-A Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)335209
2-240713870-A-G Hereditary spastic paraplegia 30 Benign (Jan 12, 2018)335210
2-240713876-C-T Hereditary spastic paraplegia 30 Uncertain significance (Jan 12, 2018)335211
2-240713881-C-T Hereditary spastic paraplegia 30 Uncertain significance (Jan 12, 2018)898884
2-240713954-G-A Hereditary spastic paraplegia 30 Uncertain significance (Jan 12, 2018)335212
2-240713991-C-G Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)895919
2-240714019-C-T Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)335213
2-240714055-G-A Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)335214
2-240714058-C-T Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)895920
2-240714064-G-A Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)895921
2-240714077-A-G Hereditary spastic paraplegia 30 Uncertain significance (Jan 12, 2018)895922
2-240714326-A-T Hereditary spastic paraplegia 30 Benign (Jan 13, 2018)335215
2-240714329-C-G Hereditary spastic paraplegia 30 Uncertain significance (Jan 12, 2018)335216
2-240714410-C-T Hereditary spastic paraplegia 30 Uncertain significance (Jan 12, 2018)335217
2-240714467-C-A Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)896198
2-240714513-C-T Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)335218
2-240714524-A-T Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)896199
2-240714568-G-A Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)896200
2-240714570-G-A Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)335219
2-240714626-C-G Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)335220
2-240714644-G-A Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)897801
2-240714732-C-T Hereditary spastic paraplegia 30 Uncertain significance (Jan 13, 2018)335221
2-240714788-T-C Hereditary spastic paraplegia 30 Benign (Jan 13, 2018)335222

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
KIF1Aprotein_codingprotein_codingENST00000498729 48106545
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.004.09e-11124789081247970.0000321
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense5.166401.13e+30.5680.000077411569
Missense in Polyphen175470.590.371884732
Synonymous0.005694854851.000.00003643504
Loss of Function8.44796.40.07260.000004791117

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00008730.0000873
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00003910.0000354
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Motor for anterograde axonal transport of synaptic vesicle precursors. {ECO:0000250}.;
Disease
DISEASE: Neuropathy, hereditary sensory, 2C (HSN2C) [MIM:614213]: A neurodegenerative disorder characterized by onset in the first decade of progressive distal sensory loss leading to ulceration and amputation of the fingers and toes. Affected individuals also develop distal muscle weakness, primarily affecting the lower limbs. {ECO:0000269|PubMed:21820098}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mental retardation, autosomal dominant 9 (MRD9) [MIM:614255]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:21376300, ECO:0000269|PubMed:25265257, ECO:0000269|PubMed:26125038, ECO:0000269|PubMed:26410750}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in KIF1A are a cause autosomal dominant spastic paraplegia. Spastic paraplegia is a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. {ECO:0000269|PubMed:25585697, ECO:0000269|PubMed:26410750}.;
Pathway
Vesicle-mediated transport;Membrane Trafficking;Kinesins;Factors involved in megakaryocyte development and platelet production;Hemostasis;COPI-dependent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;Intra-Golgi and retrograde Golgi-to-ER traffic (Consensus)

Recessive Scores

pRec
0.152

Intolerance Scores

loftool
0.438
rvis_EVS
-3.67
rvis_percentile_EVS
0.27

Haploinsufficiency Scores

pHI
0.502
hipred
Y
hipred_score
0.733
ghis
0.607

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.809

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Kif1a
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
microtubule-based movement;anterograde axonal transport;vesicle-mediated transport;interkinetic nuclear migration;cytoskeleton-dependent intracellular transport;protein transport along microtubule;anterograde neuronal dense core vesicle transport;retrograde neuronal dense core vesicle transport
Cellular component
cytosol;kinesin complex;microtubule;synaptic vesicle;axon;dendrite;neuron projection;neuronal cell body;postsynapse;axon cytoplasm
Molecular function
motor activity;microtubule motor activity;ATP binding;microtubule binding;ATP-dependent microtubule motor activity, plus-end-directed;ATPase activity;identical protein binding;protein homodimerization activity